Kala Pharmaceuticals Inc. Stock
The Kala Pharmaceuticals Inc. stock is trending slightly upwards today, with an increase of €0.000 (0.190%) compared to yesterday's price.
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 0.21 € the target price of 11 € shows a potential of 5229.46% for Kala Pharmaceuticals Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Kala Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 0.190% | -13.997% | -33.373% | -96.228% | -54.032% | -98.319% | -99.933% |
| Heron Therapeutics Inc. | -3.870% | -12.346% | -25.100% | -65.830% | -32.765% | -65.516% | -94.563% |
| Evolus Inc | 0.950% | -4.405% | 17.297% | -62.586% | -20.367% | -45.750% | -60.311% |
| Sangamo Therapeutics Inc. | -2.930% | -6.094% | 6.294% | -61.957% | -4.403% | -82.443% | -96.619% |
Comments
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at HC Wainwright from $12.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $15.00 to $33.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat